Obagi C Rx System Normal-Dry With Hydroquinone 4
Complete skin care regimen specifically formulated for normal to dry skin with 4% hydroquinone to reduce hyperpigmentation, such as dark spots and melasma, and other essential ingredients to help address the signs of skin aging caused by photoaging.
Obagi C Rx System Normal-Dry Kit Includes:
- C-Cleansing Gel
- C-Clarifying Serum (Normal to Dry Skin)
- C-Exfoliating Day Lotion
- Sun Shield Matte Broad Spectrum SPF 50
- C-Therapy Night Cream
Not available in select states including MA, MT, NH, NY, and TX, due to state regulations regarding the ability of physicians to dispense prescription drug products in their offices. For an effective, cosmetic skin-brightening option, learn about the Obagi-C® Fx System.
Important Safety Information for Obagi-C Rx C-Clarifying Serum and C-Therapy Night Cream
(contains 4% hydroquinone)
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
PRECAUTIONS FOR OBAGI C RX SYSTEN (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage OF Obagi C Rx System Normal-Dry With Hydroquinone 4: Safety and effectiveness in children below the age of 12 years have not been established.
Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.